pancreatic cancer Gene Variant Test Shows Promise for Improving Accuracy of CA19-9 for Pancreatic Cancer Detection Premium Investigators are now working to assess performance in a prospective cohort, with hopes that their method can be used to complement currently used imaging surveillance. Renovaro Biosciences to Acquire Multiomic, Multimodal AI Bioinformatics Startup Gedi Cube Premium The company, rebranded as Gedi Cube just two months ago, will become Renovaro.AI as it seeks to marry multiomics data and medical imaging in pursuit of faster cancer diagnoses and treatments. Biological Dynamics Partners With Pancreatic Cancer Consortium On Early Detection Study The firm aims to recruit at least 1,000, and up to 5,000, individuals at an elevated risk for pancreatic cancer, comparing its test to standard-of-care surveillance. Role of Super-Enhancers in Triggering Pancreatic Cancer Tumor Growth Explored in Study Investigators at the Salk Institute for Biological Studies identified DNA regulatory regions that lead to human pancreatic cancer cell line growth. Interpace Biosciences to Stop Offering Pancreatic Cancer Test After Losing CMS Reimbursement Novitas said in its coverage determination that the test has not demonstrated incremental clinical value in the prognosis of pancreatic cysts and associated cancer. May 10, 2023 Mainz Biomed, Microba Life Sciences Partner to Develop Pancreatic Cancer Screening Test Mar 16, 2023 Johns Hopkins Team Using Long-Read Sequencing to Crack Genetic Code of Pancreatic Cancer Premium Mar 1, 2023 Biological Dynamics, OHSU Partner to Validate Pancreatic Cancer Early Detection Test Feb 3, 2023 Cancer Prognoses Informed by Module-Based Approach, Study Finds Jan 31, 2023 NYU Langone Perlmutter Cancer Center to Validate Biological Dynamics Pancreatic Cancer Test Dec 21, 2022 ClearNote Health Furthers Commercialization Prospects for Pancreatic, Ovarian Cancer Tests Premium Dec 6, 2022 Bluestar Genomics to Study Pancreatic Cancer Early Detection Test in Type 2 Diabetes Patients Nov 23, 2022 Biological Dynamics Taps Two Firms to Study Utility, Economics of Pancreatic Cancer Detection Test Oct 27, 2022 Immunotherapy Response Features Identified in Pancreatic Cancer Microenvironment Oct 11, 2022 South Korean Proteomics Firm Bertis Opening CLIA Lab in San Diego by End of Year Premium Oct 5, 2022 Genomic Test IDs Pancreatic Cysts Likely to Progress to Cancer Better Than Standard Guidelines Premium Sep 8, 2022 Liquid Biopsy Tool Detects Epigenetic Signs of Cancer From Cell-Free DNA Aug 22, 2022 Single-Cell, Spatial Omic Analyses Characterize Pancreatic Cancer Cell Subpopulations Apr 13, 2022 Nurosene Health, Ontario Institute for Cancer Research Team for Pancreatic Cancer Research Mar 9, 2022 Gut Microbiome Shifts in Pancreatic Cancer Patients Point to Predictive Potential Jan 11, 2022 Seqster, National Pancreas Foundation Partner on Pancreatic Disease Registry Nov 5, 2021 Pancreatic Cancer Application Provides First Toehold for Biological Dynamics in Clinical Testing Premium Sep 13, 2021 Immunovia, JW BioScience Ink Licensing Agreement for Early Pancreatic Cancer Detection Biomarkers Aug 17, 2021 Konica Minolta Joins Precede Consortium to Improve Diagnosis and Treatment of Pancreatic Cancer May 12, 2021 Bluestar Genomics Raises $70M in Series C Funding Round Load More Breaking News Compact Gene Editing Enzyme May Improve Success Rates of Gene Therapies People in the News at Veracyte, Invitae, Mount Sinai, InterVenn Biosciences, Applied BioCode, More New Products Posted to GenomeWeb: Qiagen, IDT, Revvity, Mission Bio, NRichDx, More FDA Releases Proposed Rule for Oversight of Laboratory-Developed Tests CStone Pharmaceuticals, Genetron Companion Diagnostic Receives NMPA Approval The Scan Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants. Small Study of Gene Editing to Treat Sickle Cell Disease In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms. Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema. Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.